Abstract
To test for an association with risk for restenosis after coronary stent placement, the TNF-α and IL-10 polymorphisms were analyzed by 5′ exonuclease TaqMan assays in 162 patients who initially underwent coronary stenting. Analysis of basal and procedure coronary angiographies revealed a higher proportion of restenosis in lesions treated with bare metal stents compared with those treated with drug-eluting stents (P < 0.001). Distribution of TNF-α genotypes was similar in patients with and without restenosis. The IL-10 polymorphisms showed a moderate protective trend of the −819 TT genotype against restenosis when the lesions were analyzed (P = 0.071, OR = 0.471). Multivariate analysis confirmed a protective role for drug-eluting stents (P < 0.001, OR = 0.199) and the −819 TT genotype (P = 0.037, OR = 0.391). These results suggest the IL-10 −819 TT genotype has a protective role against in-stent restenosis.
Similar content being viewed by others
References
Baseggio L, Bienvenu J, Charlot C, Picollet J, Felman P, Coiffier B, Salles G (2001) Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin’s lymphoma patients. Exp Hematol 29:330–338
Bis JC, Heckbert SR, Smith NL, Reiner AP, Rice K, Lumley T, Hindorff LA, Marciante KD, Enquobahrie DA, Monks SA, Psaty BM (2008) Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis 198:166–173
Böse D, Leineweber K, Konorza T, Zahn A, Bröcker-Preuss M, Mann K, Haude M, Erbel R, Heusch G (2007) Release of TNF-alpha during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am J Physiol Heart Circ Physiol 292:2295–2299
Cochery-Nouvellon E, Vitry F, Cornillet-Lefebvre P, Hezard N, Gillot L, Nguyen P (2006) Interleukin-10 promoter polymorphism and venous thrombosis: a case-control study. Thromb Haemost 96:24–28
Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P (1999) Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42:1101–1108
Crivello A, Giacalone A, Scola L, Forte GI, Nuzzo D, Giacconi R, Cipriano C, Candore G, Mocchegiani E, Colonna-Romano G, Lio D, Caruso C (2006) Frequency of polymorphisms of signal peptide of TGF-beta1 and −1082G/A SNP at the promoter region of Il-10 gene in patients with carotid stenosis. Ann N Y Acad Sci 1067:288–293
Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, Virmani R (1999) Pathology of acute and chronic coronary stenting in humans. Circulation 99:44–52
Feldman LJ, Aguirre L, Ziol M, Bridou JP, Nevo N, Michel JB, Steg PG (2000) Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 101:908–916
Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB (1996) Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 94:1247–1254
Juárez-Cedillo T, Zuñiga-Ramos J, Acuña-Alonzo V, Pérez-Hernández N, Rodríguez-Pérez JM, Gallardo GJ, Sánchez-Arenas R, García-Peña MC, Granados J, Vargas-Alarcón G (2008) Genetic admixture and diversity estimations in the Mexican Mestizo population from Mexico City using 15 STR polymorphic markers. Forensic Sci Int Genet 2:37–39
Koch W, Tiroch K, von Beckerath N, Schömig A, Kastrati A (2003) Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine 24:161–171
Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE (1998) Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analysis. Circulation 98:224–233
Kooemider M (1997) Coronary stent implantation results in patients treated with ticlopidine and aspirin. Med Sci Monit 3:821–825
Kroeger KM, Carville KS, Abraham LJ (1997) The −308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391–399
Miller A (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Mintz GS, Popma JJ, Phicard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB (1996) Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 94:35–43
Monraats PS, Kurreeman FA, Pons D, Sewgobind VD, de Vries FR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Huizinga TW, Eefting D, Quax PH, Frants RR, van der Laarse A, van der Wall EE, Jukema JW (2007) Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention. Genes Immun 8:44–50
Oda K, Tanaka N, Arai T, Araki J, Song Y, Zhang L, Kuchiba A, Hosoi T, Shirasawa T, Muramatsu M, Sawabe M (2007) Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet 16:592–599
Rapold HJ, David PR, Guiteras Val P, Mata AL, Crean PA, Bourassa M (1987) Restenosis and its determinants in first and repeat coronary angioplasty. Eur Heart J 8:575–586
Rittersma SZ, Kremer Hovinga JA, Koch KT, Boekholdt SM, van Aken BE, Scheepmaker A, Bax M, Schotborgh CE, Piek JJ, Tijssen JG, Reitsma PH, de Winter RJ (2005) Relationship between in vitro lipopolysaccharide-induced cytokine response in whole blood, angiographic in-stent restenosis, and toll-like receptor 4 gene polymorphisms. Clin Chem 5:516–521
Rueda B, Roibas B, Martin J, Gonzalez-Gay MA (2007) Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. J Rheumatol 34:1535–1539
Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G et al (1994) A comparison of balloon- expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489–495
Serruys PW, van Hout B, Bonnier H, Legrand V, García E, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA (1998) Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 352:673–681
Settin A, Abdel-Hady H, El-Baz R, Saber I (2007) Gene polymorphisms of TNF-alpha(−308), IL-10(−1082), IL-6(−174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 28: 363–371
Sigwart U, Peul J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravasculat stent to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701–706
Suarez A, Castro P, Alonso R, Mozo L, Gutiérrez C (2003) Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 75:711–717
Vargas-Alarcón G, Moscoso J, Martinez-Laso J, Rodríguez-Pérez JM, Flores-Dominguez C, Serrano-Vela JI, Moreno A, Granados J, Arnaiz-Villena A (2007) Origin of Mexican Nahuas (Aztecs) according to HLA genes and their relationships with worldwide populations. Mol Immunol 44:747–755
Weiczorek SJ, Tsongalis GJ (2001) Pharmacogenomics: will it change the field of medicine? Clin Chim Acta 308:1–8
Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweil CL, Boomsma DI, Vandenbroucke JP (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170–173
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195–3199
Acknowledgments
This study was supported in part by grants from the Consejo Nacional de Ciencia y Tecnología (Grant 50352-M/24147) and Fundación Gonzalo Rios Arronte, Mexico City, Mexico. The authors are grateful to the study participants. Institutional Review Board approval was obtained for all sample collections. We would like to thank Selene Inés-Real and Silvestre Ramírez-Fuentes for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Marco Antonio Martínez-Ríos and Marco Antonio Peña-Duque contributed equally to this work.
Rights and permissions
About this article
Cite this article
Martínez-Ríos, M.A., Peña-Duque, M.A., Fragoso, J.M. et al. Tumor Necrosis Factor Alpha and Interleukin 10 Promoter Polymorphisms in Mexican Patients with Restenosis After Coronary Stenting. Biochem Genet 47, 707–716 (2009). https://doi.org/10.1007/s10528-009-9268-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-009-9268-9